Table II.
First author, year | Sex | Age, years | Metastasis site | Treatment | Survival after diagnosis | (Refs.) |
---|---|---|---|---|---|---|
Amado Villanueva, 2022 | Female | 32 | Liver | Folinic acid, 5-FU, oxaliplatin | 8 months | (43) |
Beattie, 2019 | Male | 53 | Liver | Carboplatin, paclitaxel | Not reported (>6 months) | (44) |
Sabbah, 2021 | Female | 66 | Ovary | Symptomatic | Few months | (34) |
Vailas, 2019 | Male | 66 | Lungs | Surgery, paclitaxel, carboplatin | Not reported (>12 months) | (45) |
Von Waagner, 2015 | Male | 70 | Peritoneum, liver | Surgery, radiation, capecitabine, oxaliplatin | 27 months | (23) |
Wakabayashi, 2014 | Male | 69 | Liver | Surgery, 5-FU, cisplatin, docetaxel | 36 months | (18) |
Wu, 2016 | Male | 59 | Liver, spleen | Surgery, docetaxel, cisplatin | 16 months | (46) |
Yamagata, 2019 | Male | 60 | Liver | Surgery, S-1 (novel 5-FU derivative) | 17 months | (48) |
Yang, 2020 | Female | 51 | Peritoneum | Docetaxel, cisplatin | Not reported | (47) |
5-FU, 5-fluorouracil.